CompletedNot Applicable

Extension Study for Participants of MACI00206 Study of MACI® for the Treatment of Symptomatic Articular Cartilage Defects of the Knee

Czechia, France128 participantsStarted 2010-12

Plain-language summary

To examine the 5-year efficacy and safety of MACI implant, compared with arthroscopic microfracture, in participants who received study treatment in the SUMMIT study for treatment of symptomatic articular cartilage defects of the knee.

Who can participate

Age range18 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Randomized and received study treatment (MACI or microfracture) in the SUMMIT study.

What they're measuring

Change From MACI00206 Baseline for the Participant's Knee Injury and Osteoarthritis Outcome (KOOS) Pain and Function (Sports and Recreational Activities) Scores.

Timeframe: MACI00206 Baseline to Week 156

Trial details

NCT IDNCT01251588

SponsorVericel Corporation

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2015-03

Results submitted2017-01-12

View on ClinicalTrials.gov More Articular Cartilage Defects trials